Tone at the top really does matter

The Man From FCPA Tom Fox looks at the case of disgraced pharmaceutical company Valeant and what new Chief Financial Officer Paul Herendeen has planned for the company’s future.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.